全球光學成像市場:按產品(相機,鏡頭),技術(OCT,HIS,NIR,PAT),治療領域(眼科,皮膚科,腫瘤科),應用(病理學,術中),最終用戶(醫院,研究機構)預測至2027
市場調查報告書
商品編碼
1231106

全球光學成像市場:按產品(相機,鏡頭),技術(OCT,HIS,NIR,PAT),治療領域(眼科,皮膚科,腫瘤科),應用(病理學,術中),最終用戶(醫院,研究機構)預測至2027

Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) - Global Forecast to 2027

出版日期: | 出版商: MarketsandMarkets | 英文 250 Pages | 訂單完成後即時交付

價格
簡介目錄

全球光學成像市場預計將從 2022 年的 15 億美元增長到 2027 年的 29 億美元,複合年增長率為 13.5%。

按產品劃分,軟件行業被認為是增長最快的。 對成像過程中收集的體積數據進行有效可視化和定量評估的需求使軟件成為一個不可或缺的子部分。

從應用來看,術中成像部分增長最快。 對醫療過程中可重複性和準確性的日益增長的需求以及不斷上升的勞動力成本正在推動術中市場的增長。 此外,支持術中工作流程和促進手術決策是術中領域越來越多地採用光學成像系統的主要原因。

按技術劃分,OCT(光學相干斷層掃描)部分佔有最大份額。 其原因包括在許多領域(牙科,婦科,泌尿科等)的使用增加,公司更強大的開發計劃以及對更安全,更準確和精確係統的需求不斷增長。

按地區劃分,北美在光學成像市場佔據主導地位。 越來越多的癌症患者,擴大研究以開發先進的神經成像技術,大型光學成像公司的存在以及老年人口的增加是影響市場增長的因素。

本報告分析了全球光學成像市場,包括市場的基本結構和最新發展,主要市場驅動因素和製約因素,以及按組件,車輛類型,支持技術,行業和地區劃分的細分。我們研究了前景市場動向,市場競爭狀況,主要企業概況等。

內容

第一章介紹

第二章研究方法論

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 簡介
  • 市場動態
    • 司機
    • 約束因素
    • 機會
    • 任務
  • 波特的五力分析
  • 價值鏈分析
  • 供應鏈分析
  • 監管分析
  • 專利分析
  • 價格分析
  • 貿易數據

第 6 章光學成像市場,按產品分類

  • 簡介
  • 成像系統
    • 光學成像系統
    • 光譜成像系統
  • 相機
  • 軟件
  • 鏡頭
  • 照明系統
  • 其他產品

第 7 章光學成像市場:按技術分類

  • 簡介
  • 光學相干斷層掃描 (OCT)
  • 近紅外光譜 (NIRS)
  • 高光譜成像 (HSI)
  • 光聲層析成像 (PAT)

第 8 章光學成像市場:按應用

  • 簡介
  • 病理成像
  • 術中成像

第 9 章光學成像市場:按治療領域分類

  • 簡介
  • 眼科
  • 腫瘤
  • 心髒病
  • 皮膚科
  • 神經病學
  • 其他治療領域

第 10 章光學成像市場:按最終用戶分類

  • 簡介
  • 醫院和診所
  • 研究所
  • 製藥和生物技術公司

第 11 章光學成像市場:按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲

第12章競爭格局

  • 簡介
  • 收益分成分析
  • 市場份額分析
  • 公司評估象限
  • 初創企業/中小企業評級象限
  • 競爭基準
  • 主要公司的地理足跡
  • 競爭形勢和趨勢
    • 產品發布和批准
    • 資本交易
    • 其他發展

第13章公司簡介

  • 主要公司
    • CARL ZEISS MEDITEC AG
    • TOPCON CORPORATION
    • CANON INC.
    • ABBOTT LABORATORIES INC.
    • KONINKLIJKE PHILIPS N.V.
    • PERKINELMER, INC.
    • LEICA MICROSYSTEMS (DANAHER CORPORATION)
    • AGFA-GEVAERT N.V.
    • HAMAMATSU PHOTONICS K.K.
  • 其他企業
    • HEIDELBERG ENGINEERING, INC.
    • HEADWALL PHOTONICS, INC.
    • VISIONIX (舊:LUNEAU TECHNOLOGY USA & OPTOVUE INC.)
    • OPTICAL IMAGING LTD.
    • OPTOS
    • WASATCH PHOTONICS
    • ARCSCAN INC.
    • DERMALUMICS
    • CYLITE PTY LTD.
    • MOPTIM
    • MICHELSON DIAGNOSTICS LTD.
    • THORLABS
    • ITHERAMEDICAL
    • KIBERO
    • SENO MEDICAL
    • ASPECTUS IMAGING

第14章 附錄

簡介目錄
Product Code: MD 2818

The global optical imaging market is projected to reach USD 2.9 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.5%. The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2019 and January 2023. Players in the global optical imaging market have employed various strategies to expand their global footprint and increase their market shares such as agreements, divestitures, expansions, and acquisitions.

"Software accounted for the fastest growing segment in the optical imaging product market"

Efficient visualization and quantitative evaluation of volumetric data gathered during the imaging process makes it an essential subsegment in this market. Continuous upgrades in existing systems is possible due to high tech software solutions that allows improved performance and enables precise decision making. Major players also market separate software solutions to provide enhanced capabilities to prior installed systems at end user site and ensure cost efficiency. Thus, it is the fastest growing segment in this market.

"Intra-operative accounted for the fastest growing segment in the optical imaging application market"

Increasing need for reproducibility & accuracy in medical processes and rising labor costs, propelled the intra-operative market growth. Moreover, various government bodies have extended their support through investments and funds, promoting research-related activities in this market. Support during surgical workflow and eases surgical decisions, are the major reasons for improved adoption of optical imaging systems in intraoperative sector.

"Optical coherence tomography segment accounted for the largest share in the optical imaging market"

This technique accounted for the largest share in the techniques segment owing to its implementation in numerous application areas and rising demand for use in dentistry, gynecology, urology, and others. Increased development initiative by players to launch new OCT systems is also influencing the market growth. Increased need of end users to adopt technologically superior systems such as opto-acoustic systems that is powered with the technological ability of optical coherence tomography and photoacoustic and the rising demand for safer, accurate, and precise systems have enhanced the market growth.

"North America to dominate the optical imaging market during the forecast period"

The optical imaging market in North America dominated the optical imaging market in the forecast period. The largest share of North America in the global market is attributed to the rise in cancer cases and increased research to develop advanced technology for neurological imaging. Presence of major optical imaging players and increase in geriatric population are the factors influencing the market growth. Additionally, the presence of many biopharmaceutical companies and research laboratories engaged in preclinical studies as well as the development of therapeutics in the US region of North America, also boosted the overall regional market.

Key Market Players:

The prominent players in the optical imaging market include Carl Zeiss Meditec AG (Germany), Abbott (US), Topcon Corporation (Japan), Canon Inc. (Japan), PerkinElmer, Inc. (US), Koninklijke Philips N.V. (Netherlands), Heidelberg Engineering (US), Leica Microsystems (Germany), Headwall Photonics, Inc. (US), Visionix (US), Optical Imaging Ltd. (Israel), Optos (Scotland), Wasatch Photonics (Utah), ArcScan Inc.(US), DermaLumics (Spain), Cylite Pty Ltd. (Australia), MOPTIM (Guangdong), Michelson Diagnostics Ltd. (England), Thorlabs (US), Hamamatsu Photonics K.K. (Japan), iTheraMedical (Germany), Kibero (Germany), Seno Medical (US), Aspectus Imaging (Germany), and Agfa-Gevaert N.V (Belgium).

A breakdown of the primary participants for the optical imaging market (By Supply Side) referred to for this report is provided below:

  • By Company Type: Tier 1-42%, Tier 2-31%, and Tier 3-27%
  • By Designation: C-level-30%, Director Level-45%, and Others-25%
  • By Region: North America-42%, Europe-28%, Asia Pacific-19%, RoW- 11%

Research Coverage:

The market study covers the optical imaging market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by application, by end user, by techniques, by therapeutic area, and by region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the optical imaging market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION & SCOPE
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKETS COVERED
    • FIGURE 1 OPTICAL IMAGING MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS
  • 1.7 SUMMARY OF CHANGES
  • 1.8 IMPACT OF RECESSION

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 9 COUNTRY-LEVEL ANALYSIS OF OPTICAL IMAGING MARKET
    • FIGURE 10 APPROACH 4: TOP-DOWN APPROACH
    • FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF OPTICAL IMAGING MARKET
    • FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ASSUMPTIONS
  • 2.5 ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 14 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 OPTICAL IMAGING MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 16 OPTICAL IMAGING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 17 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION)
    • FIGURE 18 OPTICAL IMAGING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 19 GEOGRAPHICAL SNAPSHOT OF OPTICAL IMAGING MARKET

4 PREMIUM INSIGHTS

  • 4.1 OPTICAL IMAGING MARKET OVERVIEW
    • FIGURE 20 INCREASING PREVALENCE OF EYE DISORDERS TO DRIVE GROWTH IN OPTICAL IMAGING MARKET
  • 4.2 NORTH AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION AND COUNTRY
    • FIGURE 21 PATHOLOGICAL IMAGING SYSTEMS DOMINATED MARKET IN 2021
  • 4.3 REGIONAL MIX: OPTICAL IMAGING MARKET
    • FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 OPTICAL IMAGING MARKET: REGIONAL SNAPSHOT
    • FIGURE 23 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 24 OPTICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing geriatric population and subsequent increase in prevalence of eye disorders
    • FIGURE 25 PERCENTAGE OF GERIATRIC POPULATION, BY REGION
    • TABLE 1 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2013 VS. 2020 VS. 2040 (MILLION)
      • 5.2.1.2 Technological innovations
      • 5.2.1.3 Growing application areas of optical imaging techniques
      • 5.2.1.4 Growing need to minimize use of radiation technologies
    • TABLE 2 KEY MARKET DRIVERS
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Reimbursement challenges
      • 5.2.2.2 Lack of skilled operators
    • TABLE 3 KEY MARKET RESTRAINTS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Expansion and market penetration opportunities in emerging economies
    • TABLE 4 GERIATRIC POPULATION TREND IN DEVELOPING REGIONS, 2020 AND 2060
      • 5.2.3.2 Growing applications in pharmaceutical & biotechnology research
    • TABLE 5 KEY MARKET OPPORTUNITIES
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Sustainability of small and medium-sized players
      • 5.2.4.2 High cost of optical imaging procedures and extensive data requirements
    • TABLE 6 KEY MARKET CHALLENGES
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 26 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 OPTICAL IMAGING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT FROM NEW ENTRANTS
    • 5.3.2 THREAT FROM SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 27 OPTICAL IMAGING MARKET: VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 28 OPTICAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 REGULATORY ANALYSIS
    • TABLE 8 STRINGENCY OF REGULATIONS FOR OPTICAL IMAGING PRODUCTS,
  • BY REGION
    • 5.6.1 NORTH AMERICA
      • 5.6.1.1 US
    • TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
      • 5.6.1.2 Canada
    • TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.6.2 EUROPE
    • 5.6.3 ASIA PACIFIC
      • 5.6.3.1 Japan
    • TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.6.3.2 China
    • TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.6.3.3 India
  • 5.7 PATENT ANALYSIS
  • 5.8 PRICING ANALYSIS
  • 5.9 TRADE DATA
    • 5.9.1 US
    • TABLE 13 TOP SUPPLIERS AND BUYERS OF OPTICAL IMAGING SYSTEMS IN US, 2020
    • 5.9.2 CHINA
    • 5.9.3 UK
    • 5.9.4 INDIA

6 OPTICAL IMAGING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 14 GLOBAL OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 6.2 IMAGING SYSTEMS
    • TABLE 15 IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 16 IMAGING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.1 OPTICAL IMAGING SYSTEMS
      • 6.2.1.1 Growing need for high-resolution imaging in ophthalmology to drive market growth
    • TABLE 17 KEY OPTICAL IMAGING SYSTEMS
    • TABLE 18 OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.2 SPECTRAL IMAGING SYSTEMS
      • 6.2.2.1 Growing need for advanced imaging techniques to promote growth
    • TABLE 19 SPECTRAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.3 CAMERAS
    • 6.3.1 BENEFITS SUCH AS BETTER SENSITIVITY AND HIGH-RESOLUTION IMAGING CAPABILITIES TO DRIVE DEMAND FOR CAMERAS
    • TABLE 20 OPTICAL IMAGING CAMERAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.4 SOFTWARE
    • 6.4.1 GROWING DEMAND FOR ADVANCED AND OPTIMIZED OPTICAL IMAGING SOFTWARE TO SUPPORT GROWTH
    • TABLE 21 OPTICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.5 LENSES
    • 6.5.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGING TO BOOST DEMAND FOR LENSES
    • TABLE 22 OPTICAL IMAGING LENSES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.6 ILLUMINATION SYSTEMS
    • 6.6.1 GROWING DEMAND FOR NON-IONIZING AND RADIATION-FREE TECHNIQUES TO BOOST MARKET GROWTH
    • TABLE 23 OPTICAL IMAGING ILLUMINATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.7 OTHER PRODUCTS
    • TABLE 24 OTHER OPTICAL IMAGING PRODUCTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

7 OPTICAL IMAGING MARKET, BY TECHNIQUE

  • 7.1 INTRODUCTION
    • TABLE 25 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  • 7.2 OPTICAL COHERENCE TOMOGRAPHY (OCT)
    • 7.2.1 RISING INNOVATIONS IN OCT TO DRIVE MARKET GROWTH
    • TABLE 26 OPTICAL COHERENCE TOMOGRAPHY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 NEAR-INFRARED SPECTROSCOPY (NIRS)
    • 7.3.1 INCREASING FUNDS BY GOVERNMENT ORGANIZATIONS AND UNIVERSITIES FOR R&D TO PROMOTE MARKET GROWTH
    • TABLE 27 NEAR-INFRARED SPECTROSCOPY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.4 HYPERSPECTRAL IMAGING (HSI)
    • 7.4.1 GROWING INDUSTRIAL APPLICATIONS OF HYPERSPECTRAL IMAGING TO BOOST GROWTH
    • TABLE 28 HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.5 PHOTOACOUSTIC TOMOGRAPHY (PAT)
    • 7.5.1 RISING CANCER CASES AND BROAD APPLICATIONS IN RESEARCH AND CLINICAL CARE TO SUPPORT GROWTH
    • TABLE 29 PHOTOACOUSTIC TOMOGRAPHY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 OPTICAL IMAGING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 30 OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 8.2 PATHOLOGICAL IMAGING
    • 8.2.1 LOW OPERATIONAL COSTS AND RELATIVE EASE OF USE TO DRIVE GROWTH
    • TABLE 31 PATHOLOGICAL IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 INTRA-OPERATIVE IMAGING
    • 8.3.1 RISING LABOR COSTS AND INCREASING NEED FOR ACCURACY IN MEDICAL PROCESSES TO DRIVE MARKET
    • TABLE 32 INTRA-OPERATIVE IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

9 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA

  • 9.1 INTRODUCTION
    • TABLE 33 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
  • 9.2 OPHTHALMOLOGY
    • 9.2.1 GROWING NUMBER OF OPHTHALMIC PROCEDURES TO PROPEL MARKET
    • TABLE 34 OPTICAL IMAGING MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.3 ONCOLOGY
    • 9.3.1 GROWING PRECLINICAL DRUG DEVELOPMENT RESEARCH ON CANCER TO PROMOTE GROWTH
    • TABLE 35 OPTICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.4 CARDIOLOGY
    • 9.4.1 ADVANCED INNOVATIONS IN OCT TECHNIQUES FOR CARDIOLOGY APPLICATIONS TO BOOST MARKET
    • TABLE 36 OPTICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.5 DERMATOLOGY
    • 9.5.1 GROWING INCIDENCE OF SKIN CANCER TO FUEL DEMAND FOR OPTICAL IMAGING
    • TABLE 37 OPTICAL IMAGING MARKET FOR DERMATOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.6 NEUROLOGY
    • 9.6.1 LOW COST AND GROWING UTILIZATION OF OPTICAL IMAGING TECHNIQUES TO PROMOTE GROWTH
    • TABLE 38 OPTICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.7 OTHER THERAPEUTIC AREAS
    • TABLE 39 OPTICAL IMAGING MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2020-2027 (USD MILLION)

10 OPTICAL IMAGING MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 40 OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.2 HOSPITALS & CLINICS
    • 10.2.1 INCREASING CLINICAL APPLICATIONS OF OPTICAL IMAGING TECHNIQUES IN HOSPITALS TO DRIVE MARKET
    • TABLE 41 OPTICAL IMAGING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 10.3 RESEARCH LABORATORIES
    • 10.3.1 AVAILABILITY OF RESEARCH FUNDING FROM PRIVATE AND GOVERNMENT ORGANIZATIONS TO PROMOTE GROWTH
    • TABLE 42 OPTICAL IMAGING MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.4.1 GREATER UTILIZATION OF OPTICAL IMAGING TECHNIQUES IN DRUG DISCOVERY PROCESSES TO SUPPORT MARKET
    • TABLE 43 OPTICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)

11 OPTICAL IMAGING MARKET, BY REGION

  • 11.1 INTRODUCTION
    • FIGURE 29 OPTICAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • TABLE 44 OPTICAL IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 11.2 NORTH AMERICA
    • 11.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 30 NORTH AMERICA: OPTICAL IMAGING MARKET SNAPSHOT
    • TABLE 45 NORTH AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 46 NORTH AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 47 NORTH AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 48 NORTH AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 49 NORTH AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 50 NORTH AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 51 NORTH AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.2.2 US
      • 11.2.2.1 Presence of several large hospitals & health systems to increase number of imaging & diagnostic procedures in country
    • TABLE 52 US: MACROECONOMIC INDICATORS
    • TABLE 53 US: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 54 US: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 55 US: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 56 US: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 57 US: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 58 US: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.2.3 CANADA
      • 11.2.3.1 Availability of research funding to drive growth
    • TABLE 59 CANADA: MACROECONOMIC INDICATORS
    • TABLE 60 CANADA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 61 CANADA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 62 CANADA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 63 CANADA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 64 CANADA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 65 CANADA: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 11.3 EUROPE
    • 11.3.1 EUROPE: RECESSION IMPACT
    • FIGURE 31 EUROPE: OPTICAL IMAGING MARKET SNAPSHOT
    • TABLE 66 EUROPE: OPTICAL IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 67 EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 68 EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 69 EUROPE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 70 EUROPE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 71 EUROPE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 72 EUROPE: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Robust healthcare spending to support market in Germany
    • TABLE 73 GERMANY: MACROECONOMIC INDICATORS
    • TABLE 74 GERMANY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 75 GERMANY: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 76 GERMANY: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 77 GERMANY: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 78 GERMANY: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 79 GERMANY: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Increasing healthcare expenditure and rising medical tourism in France to propel growth
    • TABLE 80 FRANCE: MACROECONOMIC INDICATORS
    • TABLE 81 FRANCE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 82 FRANCE: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 83 FRANCE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 84 FRANCE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 85 FRANCE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 86 FRANCE: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.4 UK
      • 11.3.4.1 Growing adoption of optical imaging techniques and in vivo research applications to drive growth
    • TABLE 87 UK: MACROECONOMIC INDICATORS
    • TABLE 88 UK: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 89 UK: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 90 UK: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 91 UK: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 92 UK: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 93 UK: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.5 ITALY
      • 11.3.5.1 Presence of major pharmaceutical & research institutes to drive market
    • TABLE 94 ITALY: MACROECONOMIC INDICATORS
    • TABLE 95 ITALY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 96 ITALY: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 ITALY: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 98 ITALY: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 99 ITALY: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 100 ITALY: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.6 SPAIN
      • 11.3.6.1 Increasing development in biomedical sciences to drive growth
    • TABLE 101 SPAIN: MACROECONOMIC INDICATORS
    • TABLE 102 SPAIN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 103 SPAIN: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 104 SPAIN: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 105 SPAIN: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 106 SPAIN: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 107 SPAIN: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 108 SHARE OF GERIATRIC POPULATION (AGED 65 YEARS AND ABOVE) IN ROE COUNTRIES
    • TABLE 109 REST OF EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 110 REST OF EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 111 REST OF EUROPE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 112 REST OF EUROPE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 113 REST OF EUROPE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 114 REST OF EUROPE: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • 11.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 32 ASIA PACIFIC: OPTICAL IMAGING MARKET SNAPSHOT
    • TABLE 115 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Established pharmaceutical & biotechnology research base to propel market
    • TABLE 122 JAPAN: MACROECONOMIC INDICATORS
    • TABLE 123 JAPAN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 124 JAPAN: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 125 JAPAN: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 126 JAPAN: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 127 JAPAN: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 128 JAPAN: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.3 CHINA
      • 11.4.3.1 Presence of large population base and favorable initiatives undertaken by authorities to aid growth
    • TABLE 129 CHINA: MACROECONOMIC INDICATORS
    • TABLE 130 CHINA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 131 CHINA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 132 CHINA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 133 CHINA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 134 CHINA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 135 CHINA: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 Rising adoption of advanced diagnostic imaging technologies by healthcare providers to boost market
    • TABLE 136 INDIA: MACROECONOMIC INDICATORS
    • TABLE 137 INDIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 138 INDIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 139 INDIA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 140 INDIA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 141 INDIA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 142 INDIA: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Growing awareness of healthcare services and rising healthcare expenditure to support market
    • TABLE 143 AUSTRALIA: MACROECONOMIC INDICATORS
    • TABLE 144 AUSTRALIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 145 AUSTRALIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 AUSTRALIA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 147 AUSTRALIA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 148 AUSTRALIA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 149 AUSTRALIA: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Growing expenditure on improved healthcare services and rising geriatric population to propel growth
    • TABLE 150 SOUTH KOREA: MACROECONOMIC INDICATORS
    • TABLE 151 SOUTH KOREA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 152 SOUTH KOREA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 SOUTH KOREA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 154 SOUTH KOREA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 155 OUTH KOREA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 156 SOUTH KOREA: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.7 REST OF ASIA PACIFIC
    • TABLE 157 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 158 REST OF ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 159 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 160 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 161 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 162 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 11.5 LATIN AMERICA
    • 11.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 163 LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 164 LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 165 LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 166 LATIN AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 167 LATIN AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 168 LATIN AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 169 LATIN AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.5.2 BRAZIL
      • 11.5.2.1 Improved GDP expenditure on healthcare
    • TABLE 170 BRAZIL: MACROECONOMIC INDICATORS
    • TABLE 171 BRAZIL: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 172 BRAZIL: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 173 BRAZIL: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 174 BRAZIL: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 175 BRAZIL: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 176 BRAZIL: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.5.3 REST OF LATIN AMERICA
    • TABLE 177 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 178 REST OF LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 180 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 181 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 182 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH
    • 11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 183 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 184 MIDDLE EAST & AFRICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 185 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 186 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 187 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 188 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
    • FIGURE 33 KEY MARKET DEVELOPMENTS (JANUARY 2020 TO JANUARY 2023)
  • 12.2 REVENUE SHARE ANALYSIS
    • FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET
  • 12.3 MARKET SHARE ANALYSIS
    • FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET, 2021
  • 12.4 COMPANY EVALUATION QUADRANT
    • 12.4.1 STARS
    • 12.4.2 EMERGING LEADERS
    • 12.4.3 PERVASIVE PLAYERS
    • 12.4.4 PARTICIPANTS
    • FIGURE 36 OPTICAL IMAGING MARKET: GLOBAL COMPANY EVALUATION QUADRANT
  • 12.5 START-UP/SME EVALUATION QUADRANT
    • 12.5.1 PROGRESSIVE COMPANIES
    • 12.5.2 STARTING BLOCKS
    • 12.5.3 RESPONSIVE COMPANIES
    • 12.5.4 DYNAMIC COMPANIES
    • FIGURE 37 OPTICAL IMAGING MARKET: GLOBAL START-UP/SME MATRIX
  • 12.6 COMPETITIVE BENCHMARKING
    • 12.6.1 COMPANY FOOTPRINT FOR KEY PLAYERS
    • 12.6.2 PRODUCT FOOTPRINT
    • 12.6.3 TECHNIQUE FOOTPRINT
    • 12.6.4 THERAPEUTIC AREA FOOTPRINT
    • 12.6.5 REGIONAL FOOTPRINT
  • 12.7 GEOGRAPHIC FOOTPRINT OF KEY PLAYERS
    • FIGURE 38 GEOGRAPHIC REVENUE MIX: KEY PLAYERS
  • 12.8 COMPETITIVE SITUATION AND TRENDS
    • 12.8.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 189 OPTICAL IMAGING MARKET: PRODUCT LAUNCHES (JANUARY 2019 TO JANUARY 2023)
    • 12.8.2 DEALS
    • TABLE 190 OPTICAL IMAGING MARKET: DEALS(JANUARY 2019 TO JANUARY 2023)
    • 12.8.3 OTHER DEVELOPMENTS
    • TABLE 191 OPTICAL IMAGING MARKET: OTHER DEVELOPMENTS (JANUARY 2019 TO JANUARY 2023)

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

    • 13.1.1 CARL ZEISS MEDITEC AG
    • TABLE 192 CARL ZEISS MEDITEC AG: BUSINESS OVERVIEW
    • FIGURE 39 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021)
    • 13.1.2 TOPCON CORPORATION
    • TABLE 193 TOPCON CORPORATION: BUSINESS OVERVIEW
    • FIGURE 40 TOPCON CORPORATION: COMPANY SNAPSHOT (2021)
    • 13.1.3 CANON INC.
    • TABLE 194 CANON INC.: BUSINESS OVERVIEW
    • FIGURE 41 CANON INC.: COMPANY SNAPSHOT (2021)
    • 13.1.4 ABBOTT LABORATORIES INC.
    • TABLE 195 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 42 ABBOTT LABORATORIES INC.: COMPANY SNAPSHOT (2021)
    • 13.1.5 KONINKLIJKE PHILIPS N.V.
    • TABLE 196 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
    • FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
    • 13.1.6 PERKINELMER, INC.
    • TABLE 197 PERKINELMER, INC.: BUSINESS OVERVIEW
    • FIGURE 44 PERKINELMER, INC.: COMPANY SNAPSHOT (2021)
    • 13.1.7 LEICA MICROSYSTEMS (DANAHER CORPORATION)
    • TABLE 198 LEICA MICROSYSTEMS (DANAHER CORPORATION): BUSINESS OVERVIEW
    • FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
    • 13.1.8 AGFA-GEVAERT N.V.
    • TABLE 199 AGFA-GEVAERT N.V.: BUSINESS OVERVIEW
    • FIGURE 46 AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2021)
    • 13.1.9 HAMAMATSU PHOTONICS K.K.
    • TABLE 200 HAMAMATSU PHOTONICS K.K.: BUSINESS OVERVIEW
    • FIGURE 47 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2021)
  • 13.2 OTHER PLAYERS
    • 13.2.1 HEIDELBERG ENGINEERING, INC.
    • TABLE 201 HEIDELBERG ENGINEERING, INC.: BUSINESS OVERVIEW
    • 13.2.2 HEADWALL PHOTONICS, INC.
    • TABLE 202 HEADWALL PHOTONICS, INC.: BUSINESS OVERVIEW
    • 13.2.3 VISIONIX (FORMERLY LUNEAU TECHNOLOGY USA & OPTOVUE INC.)
    • TABLE 203 VISIONIX: BUSINESS OVERVIEW
    • 13.2.4 OPTICAL IMAGING LTD.
    • TABLE 204 OPTICAL IMAGING LTD.: BUSINESS OVERVIEW
    • 13.2.5 OPTOS
    • TABLE 205 OPTOS: BUSINESS OVERVIEW
    • 13.2.6 WASATCH PHOTONICS
    • TABLE 206 WASATCH PHOTONICS: BUSINESS OVERVIEW
    • 13.2.7 ARCSCAN INC.
    • TABLE 207 ARCSCAN INC.: BUSINESS OVERVIEW
    • 13.2.8 DERMALUMICS
    • TABLE 208 DERMALUMICS: BUSINESS OVERVIEW
    • 13.2.9 CYLITE PTY LTD.
    • TABLE 209 CYLITE PTY LTD.: BUSINESS OVERVIEW
    • 13.2.10 MOPTIM
    • TABLE 210 MOPTIM: BUSINESS OVERVIEW
    • 13.2.11 MICHELSON DIAGNOSTICS LTD.
    • TABLE 211 MICHELSON DIAGNOSTICS LTD.: BUSINESS OVERVIEW
    • 13.2.12 THORLABS
    • TABLE 212 THORLABS: BUSINESS OVERVIEW
    • 13.2.13 ITHERAMEDICAL
    • TABLE 213 ITHERAMEDICAL: BUSINESS OVERVIEW
    • 13.2.14 KIBERO
    • TABLE 214 KIBERO: BUSINESS OVERVIEW
    • 13.2.15 SENO MEDICAL
    • TABLE 215 SENO MEDICAL: BUSINESS OVERVIEW
    • 13.2.16 ASPECTUS IMAGING
    • TABLE 216 ASPECTUS IMAGING: BUSINESS OVERVIEW
  • Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4 CUSTOMIZATION OPTIONS
  • 14.5 RELATED REPORTS
  • 14.6 AUTHOR DETAILS